Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases

• Published in: Mechanisms of ageing and development 2024-08, Vol.220, p.111944, Article 111944
• Main Authors: Nagar, Nupur, Naidu, Goutami, Panda, Santosh Kumar, Gulati, Khushboo, Singh, Ravindra Pal, Poluri, Krishna Mohan
• Format: Article
• Language: English
• Subjects: Aging; Atherosclerosis; Chemokines; Inflammation; Leukocyte recruitment
• ISSN: 0047-6374; 1872-6216; 1872-6216
• DOI: 10.1016/j.mad.2024.111944

Age-related inflammation or inflammaging is a critical deciding factor of physiological homeostasis during aging. Cardiovascular diseases (CVDs) are exquisitely associated with aging and inflammation and are one of the leading causes of high mortality in the elderly population. Inflammaging comprises dysregulation of crosstalk between the vascular and cardiac tissues that deteriorates the vasculature network leading to development of atherosclerosis and atherosclerotic-associated CVDs in elderly populations. Leukocyte differentiation, migration and recruitment holds a crucial position in both inflammaging and atherosclerotic CVDs through relaying the activity of an intricate network of inflammation-associated protein-protein interactions. Among these interactions, small immunoproteins such as chemokines play a major role in the progression of inflammaging and atherosclerosis. Chemokines are actively involved in lymphocyte migration and severe inflammatory response at the site of injury. They relay their functions via chemokine-G protein-coupled receptors-glycosaminoglycan signaling axis and is a principal part for the detection of age-related atherosclerosis and related CVDs. This review focuses on highlighting the detailed intricacies of the effects of chemokine-receptor interaction and chemokine oligomerization on lymphocyte recruitment and its evident role in clinical manifestations of atherosclerosis and related CVDs. Further, the role of chemokine mediated signaling for formulating next-generation therapeutics against atherosclerosis has also been discussed. •Aging is a critical to regulation of chemokine mediated atherogenic inflammation.•Chemokine-receptor interaction is key to atherosclerosis associated CVDs.•Chemokine oligomerization and degenerate receptor interactions modulate atherosclerosis.•Chemokine-receptor axis is a potential target for antiatherosclerosis therapeutics.